Kara Wegermann
@KWegermann
Followers
252
Following
46
Media
20
Statuses
95
@Duke_GI_ Transplant Hep | Liver nerd | Tweets my own
North Carolina, USA
Joined June 2018
🧪 How do everyday environmental exposures shape liver cancer risk?.Our review unpacks what’s known, what’s uncertain, and where research is headed. 📄 Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review.
1
1
7
Check out our manuscript in @metabolomics!.🔷Aim: find plasma oxylipins associated w/advanced fibrosis in people with HIV + HCV.🔷Model = AST + 7 oxylipins, AUC 0.93!.🔷Role of oxidative stress?. @HowardTLeeMD @snaggie1.
0
2
10
Check out our article!.@CindyMoylan_MD @snaggie1.
In @JIDJournal, @KWegermann and colleagues aim to discover lipid metabolite signatures for persons with HIV (PWH), PWH with HCV coinfection, and individuals with metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD, MASH).
0
0
0
Heart failure (HF) = common, underrecognized in MASLD patients.. *⃣ ~50% MASLD patients w/ suspected HF, ~20% diagnosed.➡️ Care pathway needed!.@FudimMarat @CindyMoylan_MD @Mayo_liverdoc @FouadChouairi @YKarachaliou @sandraau_ @CarolynAhlers @TorBiering
0
7
28
Former President Lincoln looked thoughtful when I stopped by on my morning fun. I asked him….GLP1RA or bariatric surgery?. 🗓️ TODAY.🕰️ 10-11am.Room 202B. @DDW2024 #livertwitter @LizzieAbyMD @JonathanStineMD @SamarHIbrahimMD @orenkfix @liver4kids @RotonyaC @NASH_and_coffee
1
2
17
It was 🤩 ! Catch the next 2 AASLD Academic Debates which will be just as awesome:. 🔷 Sunday 10am: Terlipressin for pts who are not LT candidates. 🔷 Monday 10am: GLP1RA vs bariatric surgery for adolescent MASLD. @LizzieAbyMD.
🚨 Don't miss out! Head to room 202A for a dynamic academic debate on alcohol-associated liver disease and liver transplants. This is a session you don't want to miss at #DDW24. 🌟 #DukeGI #LiverDisease #MedicalConference #GITwitter @KWegermann @LizzieAbyMD.
1
2
8
You guys are good! They are judging the MASLD debate on Monday at DDW. 10am, be there!.
0
1
2
What do these 3 people have in common? #DDW2024 #livertwitter . @RotonyaC .@NASH_and_coffee .@liver4kids.
1
4
7
How should we manage young adults with MASLD? . Cast your vote below, then hear all ⭐️s @SamarHIbrahimMD and @JonathanStineMD debate at #DDW2024!. 🗓️ Mon 5/20.🕰️ 10-11am.Room 202B.Emcee @orenkfix!.
2
2
10
Sad to hear of Dr. Harrison’s passing. Had the honor of introducing him as emcee for Academic Debates at TLM 2023. He was an entertaining and gracious presence. Here he is laying down the law with esteemed judges @Mayo_liverdoc @nagachalasani @RotonyaC
0
2
11
Check out our article: . 🔷 53 metabolites (lipids, cysteine) associate with HFpEF in patients with biopsy-proven MASLD . @Duke_GI_ @CindyMoylan_MD @FudimMarat @Mayo_liverdoc . Journal of the American Heart Association
ahajournals.org
0
4
17
Stoked to hear super⭐️ Dr. Sachi Oshima of @IMResidencyDuke present her work on consent for HCV NAT+ organs today! 4:30pm, Room 4, #ATC2023SanDiego, be there! @Duke_GI_.
0
2
11
RT @AASLDtweets: You won't want to miss our Academic Debates! #DDW2023 . Early TIPS for variceal: @ebtapper vs @BrettEFortuneMD. Invasive….
0
6
0
Check out this awesome poster by Sachi Oshima of @IMResidencyDuke ! $25 donation to @liverUSA = vote in poster contest!. Use of HCV NAT+ allografts:.⬇️ waitlist time.⬇️ waitlist mortality.✴️ need HCV Rx post-LT, effective and safe. @Duke_GI_ .
alfevents.org
×
0
5
18
Congrats!!.
⚡️Publication Alert📰.Congrats @alextreddy & @sarahdactyl on @foregut_journal paper on medical💊of ineffective esophageal motility!.🔹IEM🔀dysphagia.🔹Systematic review supports serotonin agonists.🔹More data needed w/ CC4.0 to assess patient outcomes.📕
0
0
1
RT @MaryEKlotman: In my Friday Message for April 21 I speak with Julius Wilder, assistant professor of medicine, about health inequities am….
0
3
0
RT @LizzieAbyMD: Ready for some 🔥🔥🔥 AASLD Academic Debates at #DDW2023?. Great topics & fantastic debate champions including: @ebtapper, @B….
0
20
0
@Julius__Wilder of @Duke_GI_ weighs in on hep C elimination alongside @AASLDPresident and Francis Collins. Star struck!
0
2
25
⬆️ WL mortality but similar post-LT survival for APAP-related ALF compared to DILI/AIH/HBV. Congrats @NatalieZWong! Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort
onlinelibrary.wiley.com
The impact of acute liver failure (ALF) etiology on waitlist (WL) and posttransplantation outcomes, independent of severity of illness, is incompletely characterized. All adults (n = 1691) listed...
1
0
1